GLP-1 drugs: what Turquoise Care paid
Turquoise Care shows a published payment figure for 5 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Turquoise Care's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.
By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.
What Turquoise Care’s payment record shows
In 2026Q1, the product Turquoise Care paid for most often was Ozempic®, at 9,053 prescriptions19 of the 15,586 to 15,847713192543 across all 8 products, or 58 percent of the published count.
Turquoise Care itself reimbursed at least $15,401,564 for these products in the quarter, about $990 per prescription. Pharmacies were paid $15,512,755 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,140.
Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Turquoise Care finally kept is lower than what is shown here, by an amount this site cannot source.
What Turquoise Care paid, product by product
For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.
| Product | Paid through | Prescriptions | Shareof this program | Program paidbefore rebates | All payers | Program per Rx |
|---|---|---|---|---|---|---|
| tirzepatideZepbound® | Fee-for-service | Withheld | n/a | Not published | Not published | Not published |
| tirzepatideMounjaro® | Both5,584 managed care, 537 direct | at least 6,1217 | 39% | $6,475,053 | $6,522,946 | $1,058 |
| semaglutideWegovy® | Both46 managed care, 26 direct | at least 7213 | <1% | $82,049 | $83,221 | $1,140 |
| semaglutideOzempic® | Both7,621 managed care, 1,432 direct | 9,05319 | 58% | $8,683,900 | $8,744,326 | $959 |
| semaglutideRybelsus® | Both | at least 10425 | <1% | $102,847 | $104,547 | $989 |
| liraglutideSaxenda® | Not published | Withheld | n/a | Not published | Not published | Not published |
| liraglutideVictoza® | Both | Withheld | n/a | Not published | Not published | Not published |
| liraglutideliraglutide (generic) | Both | at least 20743 | 1% | $57,715 | $57,715 | $279 |
Turquoise Care publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.
Against enrollment, that is 24.3 to 24.7 prescriptions per thousand people enrolled in Turquoise Care, on an average of 640,512 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.
2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.
The file withheld 40 of the 168 product-quarters it holds a row for here, which is 24 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.
Ozempic® carries a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.
21 quarters, 2021Q1 to 2026Q1
One quarter cannot tell you whether Turquoise Care pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.
Show what Turquoise Care paid for each product, quarter by quarter
| Product | 2021Q1 | 2021Q2 | 2021Q3 | 2021Q4 | 2022Q1 | 2022Q2 | 2022Q3 | 2022Q4 | 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| tirzepatideZepbound® | no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter6No row | no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter6No row | no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter6No row | no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter6No row | no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter5No row | no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter5No row | no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter5No row | no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter5No row | no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter4No row | no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter4No row | no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter4No row | no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter4No row | withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable3Withheld5 of 5 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable3Withheld6 of 6 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable3Withheld5 of 5 product codes withheld | at least 29 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld3At least$27,677 paid | at least 12 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld2At least$12,363 paid | withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable2Withheld2 of 2 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable2Withheld3 of 3 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable2Withheld5 of 5 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable1Withheld10 of 10 product codes withheld |
| tirzepatideMounjaro® | no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter12No row | no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter12No row | no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter12No row | no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter12No row | no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter11No row | no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter11No row | withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable11Withheld5 of 5 product codes withheld | at least 61 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld11At least$43,432 paid | at least 126 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld10At least$101,056 paid | at least 199 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld10At least$147,478 paid | at least 214 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld10At least$147,740 paid | at least 292 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld10At least$236,587 paid | at least 559 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld9At least$567,951 paid | at least 1,561 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld9At least$1,626,824 paid | at least 2,722 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld9At least$2,829,487 paid | at least 3,121 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld9At least$3,323,989 paid | at least 3,843 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld8At least$3,977,989 paid | at least 4,529 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld8At least$4,707,873 paid | at least 5,227 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld8At least$5,422,071 paid | at least 5,310 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld8At least$5,524,286 paid | at least 6,121 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld7At least$6,475,053 paid |
| semaglutideWegovy® | no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter18No row | no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter18No row | no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter18No row | withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable18Withheld3 of 3 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable17Withheld3 of 3 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable17Withheld2 of 2 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable17Withheld2 of 2 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable17Withheld4 of 4 product codes withheld | at least 65 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld16At least$53,079 paid | at least 30 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld16At least$27,411 paid | withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable16Withheld7 of 7 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable16Withheld5 of 5 product codes withheld | at least 14 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld15At least$17,115 paid | at least 54 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld15At least$52,402 paid | at least 133 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld15At least$123,422 paid | at least 166 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld15At least$161,955 paid | at least 108 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld14At least$106,620 paid | withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable14Withheld9 of 9 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable14Withheld10 of 10 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable14Withheld10 of 10 product codes withheld | at least 72 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld13At least$82,049 paid |
| semaglutideOzempic®range 1,226 to 10,147, down 180 on the quarter before | at least 415 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld24At least$296,155 paid | at least 755 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld24At least$416,896 paid | 1,226 paid prescriptions in the quarter (2021Q3)24Count$666,697 paid | at least 1,586 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld24At least$866,020 paid | at least 1,924 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld23At least$1,381,598 paid | at least 2,339 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld23At least$1,701,353 paid | at least 2,648 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld23At least$1,882,206 paid | at least 2,586 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld23At least$1,824,296 paid | at least 3,426 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld22At least$2,461,920 paid | 4,516 paid prescriptions in the quarter (2023Q2)22Count$3,363,808 paid | at least 4,997 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld22At least$3,866,620 paid | at least 5,145 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld22At least$4,200,794 paid | at least 5,235 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld21At least$4,949,740 paid | at least 7,731 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld21At least$7,084,262 paid | at least 8,860 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld21At least$8,355,937 paid | at least 8,985 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld21At least$8,424,188 paid | at least 9,774 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld20At least$9,573,984 paid | at least 9,984 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld20At least$9,919,365 paid | 10,147 paid prescriptions in the quarter (2025Q3)20Count$10,132,021 paid | 9,233 paid prescriptions in the quarter (2025Q4)20Count$8,880,855 paid | 9,053 paid prescriptions in the quarter (2026Q1)19Count$8,683,900 paid |
| semaglutideRybelsus® | withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable30Withheld4 of 4 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable30Withheld5 of 5 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable30Withheld5 of 5 product codes withheld | at least 12 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld30At least$9,637 paid | at least 31 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld29At least$24,436 paid | at least 36 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld29At least$27,386 paid | at least 33 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld29At least$27,640 paid | at least 172 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld29At least$136,697 paid | 381 paid prescriptions in the quarter (2023Q1)28Count$292,060 paid | at least 173 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld28At least$134,814 paid | at least 72 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld28At least$58,564 paid | at least 57 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld28At least$53,496 paid | at least 50 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld27At least$68,559 paid | at least 102 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld27At least$97,207 paid | at least 121 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld27At least$122,974 paid | at least 85 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld27At least$91,572 paid | at least 72 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld26At least$75,584 paid | at least 67 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld26At least$69,942 paid | at least 69 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld26At least$72,701 paid | at least 67 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld26At least$66,581 paid | at least 104 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld25At least$102,847 paid |
| liraglutideSaxenda® | withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable36Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2021Q2)every reporting cell was withheld, so nothing is observable36Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable36Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable36Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable35Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable35Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable35Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable35Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable34Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable34Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable34Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable34Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable33Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable33Withheld1 of 1 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable33Withheld1 of 1 product codes withheld | no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter33No row | no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter32No row | no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter32No row | no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter32No row | no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter32No row | no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter31No row |
| liraglutideVictoza®range 130 to 720 | 718 paid prescriptions in the quarter (2021Q1)42Count$647,743 paid | 636 paid prescriptions in the quarter (2021Q2)42Count$443,977 paid | 720 paid prescriptions in the quarter (2021Q3)42Count$483,163 paid | 683 paid prescriptions in the quarter (2021Q4)42Count$468,289 paid | 540 paid prescriptions in the quarter (2022Q1)41Count$447,706 paid | 511 paid prescriptions in the quarter (2022Q2)41Count$425,193 paid | 466 paid prescriptions in the quarter (2022Q3)41Count$398,844 paid | 430 paid prescriptions in the quarter (2022Q4)41Count$370,756 paid | 466 paid prescriptions in the quarter (2023Q1)40Count$397,043 paid | 413 paid prescriptions in the quarter (2023Q2)40Count$355,621 paid | 352 paid prescriptions in the quarter (2023Q3)40Count$311,847 paid | 273 paid prescriptions in the quarter (2023Q4)40Count$249,619 paid | 186 paid prescriptions in the quarter (2024Q1)39Count$149,381 paid | 138 paid prescriptions in the quarter (2024Q2)39Count$94,394 paid | 130 paid prescriptions in the quarter (2024Q3)39Count$88,373 paid | at least 58 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld39At least$40,489 paid | withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable38Withheld4 of 4 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable38Withheld3 of 3 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable38Withheld2 of 2 product codes withheld | withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable38Withheld1 of 1 product codes withheld | no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter37No row |
| liraglutideliraglutide (generic) | no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter48No row | no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter48No row | no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter48No row | no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter48No row | no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter47No row | no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter47No row | no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter47No row | no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter47No row | no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter46No row | no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter46No row | no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter46No row | no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter46No row | no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter45No row | no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter45No row | at least 17 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld45At least$8,773 paid | at least 70 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld45At least$39,456 paid | at least 180 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld44At least$90,653 paid | at least 228 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld44At least$93,519 paid | at least 266 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld44At least$114,881 paid | at least 230 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld44At least$86,061 paid | at least 207 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld43At least$57,715 paid |
What this page cannot tell you
Whether Turquoise Care covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.
Open New Mexico in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.
Compare another jurisdiction from the national comparison.
Documents this page reads
48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.
SDUD 2026, Zepbound, NM
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND 1", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, NM
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "12"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, NM
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND 2", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, NM
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like ZEPBOUND%, state NM, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, NM
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like ZEPBOUND%, state NM, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, NM
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like ZEPBOUND%, state NM, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, NM
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1345"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, NM
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1262"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, NM
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "759"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, NM
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 2", "suppression_used": "false", "number_of_prescriptions": "46"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, NM
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "27"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, NM
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like MOUNJARO%, state NM, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, NM
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "18"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, NM
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "29"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, NM
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "45"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, NM
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "21"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, NM
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.5", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, NM
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 1 M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, NM
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2655"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, NM
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "3617"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, NM
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "3182"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, NM
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1809"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, NM
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "914"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, NM
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "614"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, NM
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "44"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, NM
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "33"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, NM
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "54"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, NM
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "105"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, NM
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "66"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, NM
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "12"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, NM
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like SAXENDA%, state NM, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, NM
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like SAXENDA%, state NM, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, NM
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, NM
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, NM
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, NM
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA 18", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, NM
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like VICTOZA%, state NM, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, NM
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, NM
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "81"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, NM
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 2-", "suppression_used": "false", "number_of_prescriptions": "172"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, NM
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "201"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, NM
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2021", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 3-", "suppression_used": "false", "number_of_prescriptions": "301"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, NM
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state NM, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "NM", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "36"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, NM
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state NM, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2025", "quarter": "2", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "71"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, NM
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state NM, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "40"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, NM
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state NM, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like LIRAGLUTID%, state NM, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, NM
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state NM, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like LIRAGLUTID%, state NM, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, NM
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state NM, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "NM", "product_name": "product_name like LIRAGLUTID%, state NM, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
How the quoted row is presented, for 38 of these documents
One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.
How the quoted row is presented, for 10 of these documents
The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.
Common questions
Does a paid prescription mean Turquoise Care covers the drug?
No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.
Why do two brands of the same molecule show different numbers?
Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.
What does a withheld figure mean?
The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.